APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-Drug-Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Industry Research

Non-Drug-Eluting Devices Industry Research Report 2026

Report ID 173916750526 December 2025124 pages

Choose your research edition.

Industry ResearchNon-Drug-Eluting Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Drug-Eluting Devices Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Non-Drug-Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Drug-Eluting Devices Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Drug-Eluting Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non-Drug-Eluting Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Non-Drug-Eluting Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Non-Drug-Eluting Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Non-Drug-Eluting Devices include Teleflex Incorporated, Johnson & Johnson, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew plc., Peter Surgical and Integra Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Non-Drug-Eluting Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Non-Drug-Eluting Devices Market by Company

Teleflex Incorporated

Johnson & Johnson

Medtronic

Boston Scientific Corporation

B. Braun Melsungen AG

Stryker Corporation

Smith & Nephew plc.

Peter Surgical

Integra Lifesciences

DemeTECH Corporation

ConMed Corporation

Non-Drug-Eluting Devices Segment by Type

Implants

Sutures

Non-Drug-Eluting Devices Segment by Application

Hospital

Ambulatory Surgical Centers

Non-Drug-Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Drug-Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Drug-Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Drug-Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Non-Drug-Eluting Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Non-Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non-Drug-Eluting Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Non-Drug-Eluting Devices Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Non-Drug-Eluting Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Non-Drug-Eluting Devices Revenue of Manufacturers (2021-2026) Table 9. Global Non-Drug-Eluting Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Non-Drug-Eluting Devices Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Non-Drug-Eluting Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Non-Drug-Eluting Devices, Product Type & Application Table 14. Global Non-Drug-Eluting Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Non-Drug-Eluting Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teleflex Incorporated Company Information Table 19. Teleflex Incorporated Business Overview Table 20. Teleflex Incorporated Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio Table 22. Teleflex Incorporated Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Medtronic Company Information Table 29. Medtronic Business Overview Table 30. Medtronic Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Medtronic Non-Drug-Eluting Devices Product Portfolio Table 32. Medtronic Recent Developments Table 33. Boston Scientific Corporation Company Information Table 34. Boston Scientific Corporation Business Overview Table 35. Boston Scientific Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio Table 37. Boston Scientific Corporation Recent Developments Table 38. B. Braun Melsungen AG Company Information Table 39. B. Braun Melsungen AG Business Overview Table 40. B. Braun Melsungen AG Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio Table 42. B. Braun Melsungen AG Recent Developments Table 43. Stryker Corporation Company Information Table 44. Stryker Corporation Business Overview Table 45. Stryker Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Stryker Corporation Non-Drug-Eluting Devices Product Portfolio Table 47. Stryker Corporation Recent Developments Table 48. Smith & Nephew plc. Company Information Table 49. Smith & Nephew plc. Business Overview Table 50. Smith & Nephew plc. Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio Table 52. Smith & Nephew plc. Recent Developments Table 53. Peter Surgical Company Information Table 54. Peter Surgical Business Overview Table 55. Peter Surgical Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Peter Surgical Non-Drug-Eluting Devices Product Portfolio Table 57. Peter Surgical Recent Developments Table 58. Integra Lifesciences Company Information Table 59. Integra Lifesciences Business Overview Table 60. Integra Lifesciences Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio Table 62. Integra Lifesciences Recent Developments Table 63. DemeTECH Corporation Company Information Table 64. DemeTECH Corporation Business Overview Table 65. DemeTECH Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio Table 67. DemeTECH Corporation Recent Developments Table 68. ConMed Corporation Company Information Table 69. ConMed Corporation Business Overview Table 70. ConMed Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. ConMed Corporation Non-Drug-Eluting Devices Product Portfolio Table 72. ConMed Corporation Recent Developments Table 73. Global Non-Drug-Eluting Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Non-Drug-Eluting Devices Sales by Region (2021-2026) & (K Units) Table 75. Global Non-Drug-Eluting Devices Sales Market Share by Region (2021-2026) Table 76. Global Non-Drug-Eluting Devices Sales by Region (2027-2032) & (K Units) Table 77. Global Non-Drug-Eluting Devices Sales Market Share by Region (2027-2032) Table 78. Global Non-Drug-Eluting Devices Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2021-2026) Table 80. Global Non-Drug-Eluting Devices Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2027-2032) Table 82. North America Non-Drug-Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 84. North America Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 85. North America Non-Drug-Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Non-Drug-Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Non-Drug-Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 89. Europe Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 90. Europe Non-Drug-Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Non-Drug-Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Non-Drug-Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Non-Drug-Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Non-Drug-Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Non-Drug-Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 99. South America Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 100. South America Non-Drug-Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Non-Drug-Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 108. Global Non-Drug-Eluting Devices Sales by Type (2027-2032) & (K Units) Table 109. Global Non-Drug-Eluting Devices Sales Market Share by Type (2021-2026) Table 110. Global Non-Drug-Eluting Devices Sales Market Share by Type (2027-2032) Table 111. Global Non-Drug-Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Non-Drug-Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021-2026) Table 114. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2027-2032) Table 115. Global Non-Drug-Eluting Devices Price by Type (2021-2026) & (US$/Unit) Table 116. Global Non-Drug-Eluting Devices Price by Type (2027-2032) & (US$/Unit) Table 117. Global Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 118. Global Non-Drug-Eluting Devices Sales by Application (2027-2032) & (K Units) Table 119. Global Non-Drug-Eluting Devices Sales Market Share by Application (2021-2026) Table 120. Global Non-Drug-Eluting Devices Sales Market Share by Application (2027-2032) Table 121. Global Non-Drug-Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Non-Drug-Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021-2026) Table 124. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2027-2032) Table 125. Global Non-Drug-Eluting Devices Price by Application (2021-2026) & (US$/Unit) Table 126. Global Non-Drug-Eluting Devices Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Non-Drug-Eluting Devices Distributors List Table 130. Non-Drug-Eluting Devices Customers List Table 131. Non-Drug-Eluting Devices Industry Trends Table 132. Non-Drug-Eluting Devices Industry Drivers Table 133. Non-Drug-Eluting Devices Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Non-Drug-Eluting Devices Product Image Figure 5. Global Non-Drug-Eluting Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Non-Drug-Eluting Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Non-Drug-Eluting Devices Sales (2021-2032) & (K Units) Figure 8. Global Non-Drug-Eluting Devices Average Price (US$/Unit) & (2021-2032) Figure 9. Implants Product Image Figure 10. Sutures Product Image Figure 11. Hospital Product Image Figure 12. Ambulatory Surgical Centers Product Image Figure 13. Global Non-Drug-Eluting Devices Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Non-Drug-Eluting Devices Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Non-Drug-Eluting Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Non-Drug-Eluting Devices Sales by Region in 2025 Figure 19. Global Non-Drug-Eluting Devices Revenue by Region in 2025 Figure 20. North America Non-Drug-Eluting Devices Market Size by Country in 2025 Figure 21. North America Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 22. North America Non-Drug-Eluting Devices Revenue Market Share by Country (2021-2032) Figure 23. United States Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Non-Drug-Eluting Devices Market Size by Country in 2025 Figure 27. Europe Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 28. Europe Non-Drug-Eluting Devices Revenue Market Share by Country (2021-2032) Figure 29. Germany Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Non-Drug-Eluting Devices Market Size by Country in 2025 Figure 40. Asia Pacific Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Non-Drug-Eluting Devices Revenue Market Share by Country (2021-2032) Figure 42. China Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Non-Drug-Eluting Devices Market Size by Country in 2025 Figure 51. South America Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 52. South America Non-Drug-Eluting Devices Revenue Market Share by Country (2021-2032) Figure 53. Brazil Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Non-Drug-Eluting Devices Market Size by Country in 2025 Figure 57. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Non-Drug-Eluting Devices Revenue Market Share by Country (2021-2032) Figure 59. Egypt Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Non-Drug-Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Non-Drug-Eluting Devices Sales Market Share by Type (2021-2032) Figure 65. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021-2032) Figure 66. Global Non-Drug-Eluting Devices Price (US$/Unit) by Type (2021-2032) Figure 67. Global Non-Drug-Eluting Devices Sales Market Share by Application (2021-2032) Figure 68. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021-2032) Figure 69. Global Non-Drug-Eluting Devices Price (US$/Unit) by Application (2021-2032) Figure 70. Non-Drug-Eluting Devices Value Chain Figure 71. Non-Drug-Eluting Devices Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Non-Drug-Eluting Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Implants
  • Sutures
Applications
  • Hospital
  • Ambulatory Surgical Centers
Companies covered
  • Teleflex Incorporated
  • Johnson & Johnson
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Smith & Nephew plc.
  • Peter Surgical
  • Integra Lifesciences
  • DemeTECH Corporation
  • ConMed Corporation

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Non-Drug-Eluting Devices Market Size (2021-2032)
  4. 2.2.2 Global Non-Drug-Eluting Devices Sales (2021-2032)
  5. 2.2.3 Global Non-Drug-Eluting Devices Market Average Price (2021-2032)
  6. 2.3 Non-Drug-Eluting Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Implants
  9. 2.3.3 Sutures
  10. 2.4 Non-Drug-Eluting Devices by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Ambulatory Surgical Centers
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Non-Drug-Eluting Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Non-Drug-Eluting Devices Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Non-Drug-Eluting Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Non-Drug-Eluting Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Non-Drug-Eluting Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Non-Drug-Eluting Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Non-Drug-Eluting Devices, Established Date
  9. 3.9 Global Non-Drug-Eluting Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teleflex Incorporated
  2. 4.1.1 Teleflex Incorporated Company Information
  3. 4.1.2 Teleflex Incorporated Business Overview
  4. 4.1.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
  6. 4.1.5 Teleflex Incorporated Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Medtronic
  14. 4.3.1 Medtronic Company Information
  15. 4.3.2 Medtronic Business Overview
  16. 4.3.3 Medtronic Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
  18. 4.3.5 Medtronic Recent Developments
  19. 4.4 Boston Scientific Corporation
  20. 4.4.1 Boston Scientific Corporation Company Information
  21. 4.4.2 Boston Scientific Corporation Business Overview
  22. 4.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
  24. 4.4.5 Boston Scientific Corporation Recent Developments
  25. 4.5 B. Braun Melsungen AG
  26. 4.5.1 B. Braun Melsungen AG Company Information
  27. 4.5.2 B. Braun Melsungen AG Business Overview
  28. 4.5.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
  30. 4.5.5 B. Braun Melsungen AG Recent Developments
  31. 4.6 Stryker Corporation
  32. 4.6.1 Stryker Corporation Company Information
  33. 4.6.2 Stryker Corporation Business Overview
  34. 4.6.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
  36. 4.6.5 Stryker Corporation Recent Developments
  37. 4.7 Smith & Nephew plc.
  38. 4.7.1 Smith & Nephew plc. Company Information
  39. 4.7.2 Smith & Nephew plc. Business Overview
  40. 4.7.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
  42. 4.7.5 Smith & Nephew plc. Recent Developments
  43. 4.8 Peter Surgical
  44. 4.8.1 Peter Surgical Company Information
  45. 4.8.2 Peter Surgical Business Overview
  46. 4.8.3 Peter Surgical Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
  48. 4.8.5 Peter Surgical Recent Developments
  49. 4.9 Integra Lifesciences
  50. 4.9.1 Integra Lifesciences Company Information
  51. 4.9.2 Integra Lifesciences Business Overview
  52. 4.9.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
  54. 4.9.5 Integra Lifesciences Recent Developments
  55. 4.10 DemeTECH Corporation
  56. 4.10.1 DemeTECH Corporation Company Information
  57. 4.10.2 DemeTECH Corporation Business Overview
  58. 4.10.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
  60. 4.10.5 DemeTECH Corporation Recent Developments
  61. 4.11 ConMed Corporation
  62. 4.11.1 ConMed Corporation Company Information
  63. 4.11.2 ConMed Corporation Business Overview
  64. 4.11.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
  66. 4.11.5 ConMed Corporation Recent Developments
5 Global Non-Drug-Eluting Devices Market Scenario by Region
  1. 5.1 Global Non-Drug-Eluting Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Non-Drug-Eluting Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Non-Drug-Eluting Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Non-Drug-Eluting Devices Sales by Region: 2027-2032
  5. 5.3 Global Non-Drug-Eluting Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Non-Drug-Eluting Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Non-Drug-Eluting Devices Revenue by Region: 2027-2032
  8. 5.4 North America Non-Drug-Eluting Devices Market Facts & Figures by Country
  9. 5.4.1 North America Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Non-Drug-Eluting Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Non-Drug-Eluting Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Non-Drug-Eluting Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Non-Drug-Eluting Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Non-Drug-Eluting Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Non-Drug-Eluting Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Non-Drug-Eluting Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Non-Drug-Eluting Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Non-Drug-Eluting Devices Market Facts & Figures by Country
  41. 5.7.1 South America Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Non-Drug-Eluting Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Non-Drug-Eluting Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Non-Drug-Eluting Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Non-Drug-Eluting Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Non-Drug-Eluting Devices Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Non-Drug-Eluting Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Non-Drug-Eluting Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Non-Drug-Eluting Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Non-Drug-Eluting Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Non-Drug-Eluting Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Non-Drug-Eluting Devices Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Non-Drug-Eluting Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Non-Drug-Eluting Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Non-Drug-Eluting Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Non-Drug-Eluting Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Non-Drug-Eluting Devices Value Chain Analysis
  2. 8.1.1 Non-Drug-Eluting Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Non-Drug-Eluting Devices Production Mode & Process
  5. 8.2 Non-Drug-Eluting Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Non-Drug-Eluting Devices Distributors
  8. 8.2.3 Non-Drug-Eluting Devices Customers
9 Global Non-Drug-Eluting Devices Analyzing Market Dynamics
  1. 9.1 Non-Drug-Eluting Devices Industry Trends
  2. 9.2 Non-Drug-Eluting Devices Industry Drivers
  3. 9.3 Non-Drug-Eluting Devices Industry Opportunities and Challenges
  4. 9.4 Non-Drug-Eluting Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst